Growth factor activation in myocardial vascularization: therapeutic implications

Area of Science:

• Cardiovascular Biology
• Developmental Biology
• Physiology

Background:

• Coronary vasculature develops through vasculogenesis and angiogenesis, controlled by growth factors.
• Myocardial angiogenesis also occurs in adult hearts under stress, hypoxia, or ischemia.
• Growth factor activation by metabolic and mechanical stimuli is key to vascular development and adaptation.

Purpose of the Study:

• To review growth factor activation by metabolic and mechanical stimuli in developing and adult hearts.
• To explore the role of these stimuli in myocardial angiogenesis and arteriogenesis.
• To assess the potential of non-invasive therapies for ischemic heart conditions.

Main Methods:

• Review of experimental studies on growth factor signaling in the heart.
• Analysis of metabolic (hypoxia) and mechanical (stretch) stimuli.
• Investigation of vascular endothelial growth factor (VEGF) and other key factors.

Main Results:

• Hypoxia and stretch strongly induce VEGF and its receptors, promoting paracrine and autocrine signaling.
• Basic fibroblast growth factor (bFGF) and angiopoietins are crucial for myocardial vascularization.
• Evidence suggests mechanical and metabolic stimuli can drive angiogenesis.

Conclusions:

• Metabolic and mechanical factors are potent regulators of myocardial angiogenesis.
• VEGF, bFGF, and angiopoietins are central to heart vascularization.
• Non-invasive therapies targeting these pathways show promise for treating ischemic heart disease.